Skip to content
10-Q

Quarterly Report

Lucid Diagnostics Inc. LUCD

0001641172-25-009986

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2025 · Mar 31, 2025 68.8M sh
Shares Diluted Q1 2025 · Mar 31, 2024 45.01M sh
Shares Outstanding Q1 2025 · Mar 31, 2025 90.96M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $25.24M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $22.36M
Current Liabilities Q1 2025 · Mar 31, 2025 $36.57M
Current Liabilities Q1 2025 · Dec 31, 2024 $23.52M
Total Liabilities Q1 2025 · Mar 31, 2025 $38.17M
Total Liabilities Q1 2025 · Dec 31, 2024 $25.32M
Current Assets Q1 2025 · Mar 31, 2025 $27.54M
Current Assets Q1 2025 · Dec 31, 2024 $25.15M
Total Assets Q1 2025 · Mar 31, 2025 $32.8M
Total Assets Q1 2025 · Dec 31, 2024 $30.72M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.52
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.40
Revenue Q1 2025 · Mar 31, 2025 $828K
Revenue Q1 2025 · Mar 31, 2024 $1M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$12.61M
Stockholders Equity Q1 2025 · Mar 31, 2024 $11.89M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$2.31M
Eps Basic Q1 2025 · Mar 31, 2024 −$0.40
Rd Expense Q1 2025 · Mar 31, 2024 $1.5M
Net Income Q1 2025 · Mar 31, 2024 −$10.61M
Operating Income Q1 2025 · Mar 31, 2024 −$10.79M